Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis
Public ClinicalTrials.gov record NCT01746420. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Randomized, Single Ascending Dose, Double-blinded, Placebo Controlled, Multi-center Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis
Study identification
- NCT ID
- NCT01746420
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- BioMimetic Therapeutics
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- rhPDGF-BB Injection Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 21 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 11, 2012
- Primary completion
- Oct 20, 2014
- Completion
- Oct 20, 2014
- Last update posted
- Jul 1, 2019
2012 – 2014
United States locations
- U.S. sites
- 6
- U.S. states
- 4
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Research Center | Phoenix | Arizona | 85023 | — |
| Tucson Orthopaedic Institute | Tucson | Arizona | 85712 | — |
| NEA Baptist Clinic | Jonesboro | Arkansas | 72401 | — |
| Coastal Orthopedics & Sports Medicine | Bradenton | Florida | 34209 | — |
| Foundation for Orthopaedic Research and Education | Tampa | Florida | 33637 | — |
| OrthoCarolina | Charlotte | North Carolina | 28207 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01746420, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01746420 live on ClinicalTrials.gov.